SOLV vs. MEDP: Which Stock Is the Better Value Option?
Investors with an interest in Medical Services stocks have likely encountered both Solventum ( SOLV Quick QuoteSOLV - ) and Medpace ( MEDP Quick QuoteMEDP - ) . But which of these two stocks presents investors with the better value opportunity right now? Let's take a closer look.
Labcorp Holdings Inc. ( LH ) Hit a 52 Week High, Can the Run Continue?
Labcorp (LH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Baxter Stock Slips Despite Latest Launch to Boost Patient Monitoring
BAX launches FDA-cleared Connex 360 monitor, aiming to boost frontline care and streamline patient monitoring.
SOLV or MEDP: Which Is the Better Value Stock Right Now?
SOLV vs. MEDP: Which Stock Is the Better Value Option?
Is Solventum Corporation ( SOLV ) Stock Outpacing Its Medical Peers This Year?
Here is how Solventum (SOLV) and ANIXA BIOSCIENCES INC (ANIX) have performed compared to their sector so far this year.
SOLV Strong Q2 Results Signal Momentum: Is the Stock Worth Buying Now?
Solventum beats on Q2 earnings, raises guidance, and powers ahead with transformation despite looming tariff headwinds.
New Strong Buy Stocks for September 16th
FUTU, SITE, CSW, ATRO and SOLV have been added to the Zacks Rank #1 (Strong Buy) List on September 16, 2025.
This Eaton Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday - Celsius Holdings ( NASDAQ:CELH ) , Eaton Corp ( NYSE:ETN )
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
Why Thermo Fisher Scientific Stock Tumbled Today
Investors seemed unhappy about some major spending news from the company.
The Zacks Analyst Blog Highlights IBM, Goldman Sachs Group and Thermo Fisher Scientific
IBM, Goldman Sachs and Thermo Fisher stand out in Zacks research with AI growth, strong banking results and new product launches.
Top Stock Reports for IBM, Goldman Sachs & Thermo Fisher
IBM beats Q2 estimates with hybrid cloud and AI growth, but faces consulting weakness and macro headwinds.
MediWound Revenue Jumps 43% in Q2
MediWound ( NASDAQ:MDWD ) reported fiscal second quarter 2025 results on Aug. 14, 2025, with revenue rising 43% quarter over quarter to $5.7 million, driven by higher product sales and a favorable mix. The company advanced its Phase III EscharEx VALUE trial, expanded NexoBrid's U.S. presence, and ...
MediWound ( MDWD ) Q2 2025 Earnings Call Transcript
Image source: The Motley Fool.Thursday, August 14, 2025 at 8:30 a.m. ETChief Executive Officer - Ofer GonenContinue reading ...
Here's How Much a $1000 Investment in Thermo Fisher Scientific Made 10 Years Ago Would Be Worth Today
Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.
Warren Buffett Disciple Seth Klarman's Baupost Group Increases Alphabet, Dollar General Holdings In Q2 - Dollar General ( NYSE:DG ) , Amcor ( NYSE:AMCR )
Renowned value investor Seth Klarman's Baupost Group LLC expanded its positions in Alphabet Inc. GOOG GOOGL and Dollar General Corp. DG during the second quarter of 2025, according to the firm's latest 13F filing with the Securities and Exchange Commission.
Solventum Stock Gains on Q2 Earnings & Revenue Beat, Margins Improve
SOLV jumps 5% as Q2 earnings and revenues beat estimates. EPS outlook raised on broad-based segment growth.
Solventum ( SOLV ) Q2 2025 Earnings Call Transcript
Image source: The Motley Fool.Thursday, August 7, 2025, at 4:30 p.m. ETNeed a quote from a Motley Fool analyst? Email [email protected] reading ...
Solventum ( SOLV ) Fiscal Q2 EPS Jumps 8%
Solventum ( NYSE:SOLV ) , the health technology company known for medical devices and digital health solutions, reported its earnings for the second quarter of fiscal 2025 on August 7, 2025. The company posted revenue and adjusted earnings per share that exceeded analyst expectations.
Solventum ( SOLV ) Beats Q2 Earnings and Revenue Estimates
Solventum (SOLV) delivered earnings and revenue surprises of +16.55% and +1.87%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Can Solventum Sustain Growth Amid Tariff Headwinds in Q2 Earnings?
SOLV's Q2 earnings are likely to test whether solid segment growth can offset tariff and ERP-related pressures.
Ahead of Solventum ( SOLV ) Q2 Earnings: Get Ready With Wall Street Estimates for Key Metrics
Beyond analysts' top-and-bottom-line estimates for Solventum (SOLV), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended June 2025.
Thermo Fisher Posts 3% Q2 Rise
Thermo Fisher Scientific ( NYSE:TMO ) , a leading provider of scientific instrumentation, reagents and consumables, and specialty diagnostics, reported its second quarter results for fiscal 2025 on July 23, 2025. The company delivered higher revenue and non-GAAP earnings per share than Wall ...
If You Invested $1000 in Thermo Fisher Scientific a Decade Ago, This is How Much It'd Be Worth Now
Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.
Ensemble Announces Strategic Revenue Cycle Partnership with Methodist Le Bonheur Healthcare
CINCINNATI, Ohio, July 16, 2025 ( GLOBE NEWSWIRE ) -- Ensemble, the nation's leading revenue cycle managed services partner for healthcare organizations, announced today that Methodist Le Bonheur Healthcare ( MLH ) has selected it as its strategic revenue cycle management partner.
3M Unusual Options Activity For July 14 - 3M ( NYSE:MMM )
Deep-pocketed investors have adopted a bearish approach towards 3M MMM, and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today.
Is the Options Market Predicting a Spike in Solventum Stock?
Investors need to pay close attention to SOLV stock based on the movements in the options market lately.
Thermo Fisher Stock Hurt by Macroeconomic Woes, Tough Competition
TMO grapples with macro pressures, rising expenses and fierce competition, but bets on acquisitions to fuel recovery.
Check Out What Whales Are Doing With MMM - 3M ( NYSE:MMM )
Investors with significant funds have taken a bearish position in 3M MMM, a development that retail traders should be aware of. This was brought to our attention today through our monitoring of publicly accessible options data at Benzinga.
SOLV's Strong Q1 Signals Turnaround: Is the Stock Worth Betting Now?
Solventum beats Q1 estimates, raises guidance, and powers ahead with transformation despite looming tariff headwinds.
Major Exercise Alert: John P. Banovetz Exercises Options Worth $139K At 3M - 3M ( NYSE:MMM )
A significant insider transaction involving the exercise of company stock options was reported on May 27, by John P. Banovetz, Executive Vice President at 3M MMM, as per the latest SEC filing. What Happened: The latest Form 4 filing on Tuesday with the U.S.
MediWound ( MDWD ) Q1 2025 Earnings Call Transcript
Image source: The Motley Fool.Wednesday, May 21, 2025, at 8:30 a.m. EDTChief Executive Officer - Ofer GonenContinue reading ...
MediWound Reports First Quarter 2025 Financial Results and Provides Corporate Update
VALUE Phase III trial of EscharEx® in venous leg ulcers advancing as planned ...
Insider Move: David P Bozeman Invests $195K In 3M Stock - 3M ( NYSE:MMM )
On May 14, a substantial insider purchase was made by David P Bozeman, Board Member at 3M MMM, as per the latest SEC filing. What Happened: In a recent Form 4 filing with the U.S.
Bullish Move: Thomas K Brown Shows Confidence, Acquires $195K In 3M Stock - 3M ( NYSE:MMM )
A notable insider purchase on May 14, was reported by Thomas K Brown, Director at 3M MMM, based on the most recent SEC filing. What Happened: A Form 4 filing with the U.S. Securities and Exchange Commission on Wednesday unveiled that Brown made a notable purchase of 1,297 shares of 3M, valuing at ...
3M Director Trades $195K In Company Stock - 3M ( NYSE:MMM )
Disclosed in the latest SEC filing, a significant insider purchase on May 14, involves Audrey Choi, Director at 3M MMM. What Happened: Choi made a significant move by purchasing 1,297 shares of 3M as reported in a Form 4 filing with the U.S. Securities and Exchange Commission.
Eye On Growth: Anne H Chow Adds $195K Of 3M Stock To Portfolio - 3M ( NYSE:MMM )
Anne H Chow, Director at 3M MMM, disclosed an insider purchase on May 14, based on a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Wednesday showed that Chow purchased 1,297 shares of 3M. The total transaction amounted to $195,000.
3M Board Member Trades $195K In Company Stock - 3M ( NYSE:MMM )
It was revealed in a recent SEC filing that James R Fitterling, Board Member at 3M MMM made a noteworthy insider purchase on May 14,. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Wednesday showed that Fitterling purchased 1,297 shares of 3M.
Major Purchase Alert: Suzan Kereere Invests $195K In 3M Stock - 3M ( NYSE:MMM )
A new SEC filing reveals that Suzan Kereere, Director at 3M MMM, made a notable insider purchase on May 14,. What Happened: Kereere demonstrated confidence in 3M by purchasing 1,297 shares, as reported in a Form 4 filing with the U.S. Securities and Exchange Commission on Wednesday.
Director At 3M Buys $195K of Stock - 3M ( NYSE:MMM )
A new SEC filing reveals that David B Dillon, Director at 3M MMM, made a notable insider purchase on May 14,. What Happened: Dillon's recent move, as outlined in a Form 4 filing with the U.S. Securities and Exchange Commission on Wednesday, involves purchasing 1,297 shares of 3M.
Gregory R Page Boosts Confidence With $195K Purchase Of 3M Stock - 3M ( NYSE:MMM )
It was revealed in a recent SEC filing that Gregory R Page, Director at 3M MMM made a noteworthy insider purchase on May 14,. What Happened: In a significant move reported in a Form 4 filing with the U.S.
Positive Signal: Thomas W Sweet Shows Faith, Buying $195K In 3M Stock - 3M ( NYSE:MMM )
It was revealed in a recent SEC filing that Thomas W Sweet, Director at 3M MMM made a noteworthy insider purchase on May 14,. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Wednesday showed that Sweet purchased 1,297 shares of 3M. The total transaction amounted ...
Pedro Pizarro Takes a Bullish Stance: Acquires $195K In 3M Stock - 3M ( NYSE:MMM )
It was revealed in a recent SEC filing that Pedro Pizarro, Director at 3M MMM made a noteworthy insider purchase on May 14,. What Happened: In a Form 4 filing on Wednesday with the U.S. Securities and Exchange Commission, it was disclosed that Pizarro bought 1,297 shares of 3M, amounting to a ...
Solventum ( SOLV ) Just Overtook the 200-Day Moving Average
When a stock breaks out above the 200-day simple moving average, good things could be on the horizon. How should investors react?
3 "Top Picks" From Wall Street That Are Magnificent Buys Right Now
UBS analyst Amit Mehrotra recently added Honeywell International ( NASDAQ: HON ) to his list of "top picks," which also includes industrials Johnson Controls ( NYSE: JCI ) and 3M ( NYSE: MMM ) . All three have substantive potential to outperform, and these are the stocks investors should be ...
Solventum Stock Gains on Q1 Earnings & Revenue Beat, Margins Decline
SOLV's first-quarter earnings showcase strong segmental performance. However, declining margins raise concerns.
Solventum ( SOLV ) Tops Q1 Earnings and Revenue Estimates
Solventum (SOLV) delivered earnings and revenue surprises of 12.61% and 3.37%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Solventum Q1 Earnings Likely to Reflect Higher Costs & Expenses
SOLV's Q1 performance is likely to have been hurt by below-par revenue growth in several markets, coupled with currency headwinds. Improved pricing might have offset the sales decline.
Clear Aligners Market Size Projected to Surge $21.75 Billion Growth by 2031, With CAGR of 18.8% | The Insight Partners
US & Canada, May 05, 2025 ( GLOBE NEWSWIRE ) -- According to a new comprehensive report from The Insight Partners, the global clear aligners market is growing owing to the increasing prevalence of dental problems such as malocclusion and surging demand for dental aesthetic solutions.
SOLV vs. DOCS: Which Stock Is the Better Value Option?
Investors looking for stocks in the Medical Services sector might want to consider either Solventum ( SOLV Quick QuoteSOLV - ) or Doximity ( DOCS Quick QuoteDOCS - ) . But which of these two companies is the best option for those looking for undervalued stocks? Let's take a closer look.
3M Options Trading: A Deep Dive into Market Sentiment - 3M ( NYSE:MMM )
Deep-pocketed investors have adopted a bullish approach towards 3M MMM, and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today.
